Bempegaldesleukin
贝培阿地白介素
Report date: 2026/05/18 20:02:07
Base Information
Drug NameBempegaldesleukin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[21]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[29]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNektar Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesBristol Myers Squibb SrlcompanyBristol-Myers Squibb (China) Investment Co LtdNektar Therapeutics +[4]
Inactive CompaniesPfizer IncSfj Pharmaceuticals IncUniversity Of Wisconsin-Madison
Active Indications +[6]
Inactive Indications +[15]
Other Information
ATC CodeN/A
Related LinksN/A